Posted on: 27 February, 2023
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best.
Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields.
The study is based on metrics from Scopus, a.....
Read more
Category: Research Excellence
Posted on: 14 February, 2023
We are pleased to announce the successful recipients of our annual Kolling Institute awards program.
Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling.
The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well a.....
Read more
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 13 February, 2023
We would like to congratulate Professor Carol Pollock who has received a highly prestigious award for her extraordinary commitment to research.
The International Society of Nephrology has announced Professor Pollock is the 2023 recipient of the Alfred Newton Richards award for outstanding research in the field of nephrology.
Carol has welcomed the news.
“I am extremely honoured to be rec.....
Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence
Posted on: 07 December, 2022
Generous funding provided through the Douglas and Lola Douglas scholarship is strengthening evidence around the long term impacts on children born to mothers with obesity and gestational diabetes.
Endocrinologist and Kolling Institute researcher Dr Tessa Weir has been able to continue her valuable research as a result of being awarded the scholarship.
“I am incredibly grateful for t.....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 11 November, 2022
Kolling researcher and Royal North Shore Hospital endocrinologist Associate Professor Sarah Glastras will have a key role in a national effort to improve long-term outcomes for those with diabetes.
The initiative has brought dozens of experts from across the country together under the banner of the Australian Centre for Accelerating Diabetes Innovations Research.
International collaborat.....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 17 October, 2022
We would like to congratulate Professors Carol Pollock and Gemma Figtree who have received significant National Health and Medical Research Council Investigator Grants.
Despite a tremendously competitive field, both clinician/researchers have been awarded $2 million to progress their world-leading research and improve long-term patient outcomes.
The announcement highlights the experience.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 16 September, 2022
Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock.
Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme.
The listing aims to help those with the c.....
Read more
Category: Cardiovascular and Renal Research, New Treatment
Posted on: 04 September, 2022
Ambitious leadership, functional wellbeing and a passion for collaboration
An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve.....
Read more
Category: Research Excellence
Posted on: 10 August, 2022
We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory.
The condition is a global health issue, which now affects more than 13 per cent of the worldwide population.
Chronic kidney disease is a progressive disease that leads to end-stage kidney failur.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 23 March, 2022
There are calls for a greater focus on weight management following new research defining the relationship between obesity and pregnancy-related complications for mother and baby.
The study follows an increase in obesity levels globally as well as a rise in prevalence during pregnancy. Today, more than 20 per cent of Australian women have obesity at the time of conception.
Kolling Institu.....
Read more
Category: Research Excellence